PPARγ Agonist-Loaded PLGA-PEG Nanocarriers as a Potential Treatment for Alzheimer’s Disease: In vitro and in vivo Studies [Corrigendum]

PPARγ Agonist-Loaded PLGA-PEG Nanocarriers as a Potential Treatment for Alzheimer’s Disease: In vitro and in vivo Studies [Corrigendum]

Silva-Abreu M, Calpena AC, Andrés-Benito P, et al. Int J Nanomedicine. 2018;13:5577–5590. In the published article, there was an error in Figure 6A on page 5585. The image for Rhod-NPs was duplicated by a mislabeling of the image files. A new image for Rhod-NPs has been updated...

Full description

Bibliographic Details
Main Authors: Silva-Abreu M, Calpena AC, Andrés-Benito P, Aso E, Romero IA, Roig-Carles D, Gromnicova R, Espina M, Ferrer I, García ML, Male D
Format: Article
Language:English
Published: Dove Medical Press 2023-07-01
Series:International Journal of Nanomedicine
Subjects:
nanoparticle
alzheimer’s disease
blood brain barrier
brain endothelium
pioglitazone
app/ps1 transgenic mouse.
Online Access:https://www.dovepress.com/corrigendum-ppargamma-agonist-loaded-plga-peg-nanocarriers-as-a-potent-peer-reviewed-fulltext-article-IJN

Internet

https://www.dovepress.com/corrigendum-ppargamma-agonist-loaded-plga-peg-nanocarriers-as-a-potent-peer-reviewed-fulltext-article-IJN

Similar Items